Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 110,856 | 107,036 | 100,395 | 99,734 | 91,713 |
| Operating Income | -110,856 | -107,036 | -100,395 | -99,734 | -91,713 |
| Other Income | 3,486 | 1,717 | 777 | 385 | 106 |
| Pre-tax Income | -107,370 | -105,319 | -99,618 | -99,349 | -91,607 |
| Net Income Continuous | -107,370 | -105,319 | -99,618 | -99,349 | -91,607 |
| Net Income | $-107,370 | $-105,319 | $-99,618 | $-99,349 | $-91,607 |
| EPS Basic Total Ops | -0.50 | -0.65 | -0.63 | -0.63 | -0.58 |
| EPS Basic Continuous Ops | -0.50 | -0.64 | -0.63 | -0.63 | -0.58 |
| EPS Diluted Total Ops | -0.50 | -0.65 | -0.63 | -0.63 | -0.58 |
| EPS Diluted Continuous Ops | -0.50 | -0.64 | -0.63 | -0.63 | -0.58 |
| EBITDA(a) | $-106,137 | $-101,983 | $-94,065 | $-95,027 | $-86,194 |